Guidance on the new policy from the Department for Science, Innovation and Technology (DSIT) notes that qualifying for ...

Britain said a single case of atypical Bovine Spongiform Encephalopathy (BSE) had been confirmed on a farm in England and the ...

Ministers are reviewing a controversial medicine tax that pharmaceutical companies say makes Britain 'uninvestable' as part ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

Last week, Relonchem had secured another market authorisation for its Gabapentin oral solution, 50 mg/ml, from the UKMHRA. It ...

The U.S. has a $12 billion trade surplus with the United Kingdom, meaning it already exports more than it imports. Meanwhile, ...

A number of US pharmaceutical groups have recently made announcements about expanding domestic manufacturing. These include ...